Research graph
References from Synergistic Antitumor Effects and Reduced Systemic Toxicity of Berberine Chloride Combined With Cisplatin in a Female BALB/c Mouse Xenograft Model. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3390/biom9110735
10.3390/biom9110735 · External reference
10.3390/antiox8060185
10.3390/antiox8060185 · External reference
10.1016/j.breast.2022.08.010
10.1016/j.breast.2022.08.010 · External reference
10.1007/s10555‐012‐9392‐6
10.1007/s10555‐012‐9392‐6 · External reference
10.5530/pj.2024.16.165
10.5530/pj.2024.16.165 · External reference
10.1177/106002809302700408
10.1177/106002809302700408 · External reference
10.1007/s00280‐020‐04050‐y
10.1007/s00280‐020‐04050‐y · External reference
Berberine and Chemotherapeutic Drugs Synergistically Inhibits Cell Proliferation and Migration of Breast Cancer Cells
2018 · External reference
10.3389/fphar.2019.01614/full
10.3389/fphar.2019.01614/full · External reference
Unresolved reference
2012 · External reference
10.1159/000089171
10.1159/000089171 · External reference
10.1016/j.fct.2013.09.003
10.1016/j.fct.2013.09.003 · External reference
10.1016/j.fbio.2020.100547
10.1016/j.fbio.2020.100547 · External reference
10.1002/ijc.31937
10.1002/ijc.31937 · External reference
10.1007/s00432-014-1665-8
10.1007/s00432-014-1665-8 · External reference
10.1016/j.amjms.2021.10.037
10.1016/j.amjms.2021.10.037 · External reference
10.1021/acs.jafc.3c07565
10.1021/acs.jafc.3c07565 · External reference
10.1016/j.lfs.2015.06.022
10.1016/j.lfs.2015.06.022 · External reference
10.3748/wjg.v23.i14.2511
10.3748/wjg.v23.i14.2511 · External reference
10.1007/978-981-32-9620-6_9
10.1007/978-981-32-9620-6_9 · External reference
10.1016/s1470‐2045(12)70472‐2
10.1016/s1470‐2045(12)70472‐2 · External reference
10.1016/j.phrs.2008.01.001
10.1016/j.phrs.2008.01.001 · External reference
10.1371/journal.pone.0021416
10.1371/journal.pone.0021416 · External reference
10.1007/s00044‐013‐0796‐9
10.1007/s00044‐013‐0796‐9 · External reference
10.1093/toxsci/kfj031
10.1093/toxsci/kfj031 · External reference
10.1016/j.biomaterials.2013.02.067
10.1016/j.biomaterials.2013.02.067 · External reference
10.1007/s40620‐017‐0392‐z
10.1007/s40620‐017‐0392‐z · External reference
10.3390/inorganics13070246
10.3390/inorganics13070246 · External reference
10.3390/toxins2112490
10.3390/toxins2112490 · External reference
10.1007/s002800050834
10.1007/s002800050834 · External reference
10.1016/0304‐4165(79)90289‐7
10.1016/0304‐4165(79)90289‐7 · External reference
10.1021/acsomega.0c06288
10.1021/acsomega.0c06288 · External reference
10.14670/hh‐26.333
10.14670/hh‐26.333 · External reference
10.3390/pharmaceutics14091913
10.3390/pharmaceutics14091913 · External reference
10.1002/cbin.70165
10.1002/cbin.70165 · External reference
10.18632/oncotarget.9968
10.18632/oncotarget.9968 · External reference
10.2147/jep.s267383
10.2147/jep.s267383 · External reference
10.1158/1055-9965.epi-15-0578
10.1158/1055-9965.epi-15-0578 · External reference
10.7314/apjcp.2013.14.10.6089
10.7314/apjcp.2013.14.10.6089 · External reference
10.1186/s12885‐019‐5791‐1
10.1186/s12885‐019‐5791‐1 · External reference
10.3892/or.2016.4785
10.3892/or.2016.4785 · External reference
10.3389/fonc.2022.993775
10.3389/fonc.2022.993775 · External reference
10.3390/ijms19123903
10.3390/ijms19123903 · External reference
